Keros Therapeutics (KROS – Research Report) received a Hold rating and price target from TD Cowen analyst Tyler Van Buren today. The company’s shares opened today at $18.71. Pick the best ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback